Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
The CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differe...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3429433?pdf=render |
_version_ | 1817994849541947392 |
---|---|
author | Balaji Krishnamachary Marie-France Penet Sridhar Nimmagadda Yelena Mironchik Venu Raman Meiyappan Solaiyappan Gregg L Semenza Martin G Pomper Zaver M Bhujwalla |
author_facet | Balaji Krishnamachary Marie-France Penet Sridhar Nimmagadda Yelena Mironchik Venu Raman Meiyappan Solaiyappan Gregg L Semenza Martin G Pomper Zaver M Bhujwalla |
author_sort | Balaji Krishnamachary |
collection | DOAJ |
description | The CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differentiation and facilitates invasion and metastasis. Here we have investigated the effect of hypoxia on CD44 and two of its isoforms in MDA-MB-231 and SUM-149 triple negative human breast cancer cells and MDA-MB-231 tumors using imaging and molecular characterization.The roles of hypoxia and hypoxia inducible factor (HIF) in regulating the expression of CD44 and its variant isoforms (CD44v6, CD44v7/8) were investigated in human breast cancer cells, by quantitative real-time polymerase chain reaction (qRT-PCR) to determine mRNA levels, and fluorescence associated cell sorting (FACS) to determine cell surface expression of CD44, under normoxic and hypoxic conditions. In vivo imaging studies with tumor xenografts derived from MDA-MD-231 cells engineered to express tdTomato red fluorescence protein under regulation of hypoxia response elements identified co-localization between hypoxic fluorescent regions and increased concentration of (125)I-radiolabeled CD44 antibody.Our data identified HIF-1α as a regulator of CD44 that increased the number of CD44 molecules and the percentage of CD44 positive cells expressing variant exons v6 and v7/8 in breast cancer cells under hypoxic conditions. Data from these cell studies were further supported by in vivo observations that hypoxic tumor regions contained cells with a higher concentration of CD44 expression. |
first_indexed | 2024-04-14T01:57:33Z |
format | Article |
id | doaj.art-dec1857a58b74b2990b63b8d13a9b3e8 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-04-14T01:57:33Z |
publishDate | 2012-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-dec1857a58b74b2990b63b8d13a9b3e82022-12-22T02:18:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4407810.1371/journal.pone.0044078Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.Balaji KrishnamacharyMarie-France PenetSridhar NimmagaddaYelena MironchikVenu RamanMeiyappan SolaiyappanGregg L SemenzaMartin G PomperZaver M BhujwallaThe CD44 transmembrane glycoproteins play multifaceted roles in tumor progression and metastasis. CD44 expression has also been associated with stem-like breast cancer cells. Hypoxia commonly occurs in tumors and is a major cause of radiation and chemo-resistance. Hypoxia is known to inhibit differentiation and facilitates invasion and metastasis. Here we have investigated the effect of hypoxia on CD44 and two of its isoforms in MDA-MB-231 and SUM-149 triple negative human breast cancer cells and MDA-MB-231 tumors using imaging and molecular characterization.The roles of hypoxia and hypoxia inducible factor (HIF) in regulating the expression of CD44 and its variant isoforms (CD44v6, CD44v7/8) were investigated in human breast cancer cells, by quantitative real-time polymerase chain reaction (qRT-PCR) to determine mRNA levels, and fluorescence associated cell sorting (FACS) to determine cell surface expression of CD44, under normoxic and hypoxic conditions. In vivo imaging studies with tumor xenografts derived from MDA-MD-231 cells engineered to express tdTomato red fluorescence protein under regulation of hypoxia response elements identified co-localization between hypoxic fluorescent regions and increased concentration of (125)I-radiolabeled CD44 antibody.Our data identified HIF-1α as a regulator of CD44 that increased the number of CD44 molecules and the percentage of CD44 positive cells expressing variant exons v6 and v7/8 in breast cancer cells under hypoxic conditions. Data from these cell studies were further supported by in vivo observations that hypoxic tumor regions contained cells with a higher concentration of CD44 expression.http://europepmc.org/articles/PMC3429433?pdf=render |
spellingShingle | Balaji Krishnamachary Marie-France Penet Sridhar Nimmagadda Yelena Mironchik Venu Raman Meiyappan Solaiyappan Gregg L Semenza Martin G Pomper Zaver M Bhujwalla Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. PLoS ONE |
title | Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. |
title_full | Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. |
title_fullStr | Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. |
title_full_unstemmed | Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. |
title_short | Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. |
title_sort | hypoxia regulates cd44 and its variant isoforms through hif 1α in triple negative breast cancer |
url | http://europepmc.org/articles/PMC3429433?pdf=render |
work_keys_str_mv | AT balajikrishnamachary hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT mariefrancepenet hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT sridharnimmagadda hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT yelenamironchik hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT venuraman hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT meiyappansolaiyappan hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT gregglsemenza hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT martingpomper hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer AT zavermbhujwalla hypoxiaregulatescd44anditsvariantisoformsthroughhif1aintriplenegativebreastcancer |